| Ascend Counseling, Llc | |
|
1145 Tennyson Ln Naperville IL 60540-0335 | |
| (773) 209-5932 | |
| Not Available |
| Full Name | Ascend Counseling, Llc |
|---|---|
| Speciality | Counselor |
| Location | 1145 Tennyson Ln, Naperville, Illinois |
| Authorized Official Name and Position | Robert Foreman (CREDENTIALING) |
| Authorized Official Contact | 3063130069 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ascend Counseling, Llc 1145 Tennyson Ln Naperville IL 60540-0335 Ph: (773) 209-5932 | Ascend Counseling, Llc 1145 Tennyson Ln Naperville IL 60540-0335 Ph: (773) 209-5932 |
| NPI Number | 1053021584 |
|---|---|
| Provider Enumeration Date | 11/23/2022 |
| Last Update Date | 11/23/2022 |
| Certification Date | 11/23/2022 |
| Medicare PECOS PAC ID | 6103299466 |
|---|---|
| Medicare Enrollment ID | O20230307002035 |
News Archive
Although targeted therapies have produced dramatic advances in our ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem.
PBS NewsHour on Monday aired the second installment in its "Food for 9 Billion" series, in which "Sam Eaton of Homelands Productions goes to the fishing village of Humay-Humay" in the Philippines and "speaks with families about their concerns that future generations won't enjoy the same access to fish as a food staple and way of life," the PBS NewsHour blog "The Rundown" reports.
Over the course of the 20th Century, doctors waged war against infectious bacterial illness with the best new weapon they had: antibiotics.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, said today that the recent announcement by the Centers for Medicare & Medicade Services (CMS) of a 15% increase in the payment rate of proton therapy for hospital based centers beginning in 2012 strengthens the economic case for the proton centers now under development by the Company.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053021584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Sara Reed |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1124548441 PECOS PAC ID: 2163789496 Enrollment ID: I20171122000203 |
News Archive
Although targeted therapies have produced dramatic advances in our ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem.
PBS NewsHour on Monday aired the second installment in its "Food for 9 Billion" series, in which "Sam Eaton of Homelands Productions goes to the fishing village of Humay-Humay" in the Philippines and "speaks with families about their concerns that future generations won't enjoy the same access to fish as a food staple and way of life," the PBS NewsHour blog "The Rundown" reports.
Over the course of the 20th Century, doctors waged war against infectious bacterial illness with the best new weapon they had: antibiotics.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, said today that the recent announcement by the Centers for Medicare & Medicade Services (CMS) of a 15% increase in the payment rate of proton therapy for hospital based centers beginning in 2012 strengthens the economic case for the proton centers now under development by the Company.
› Verified 9 days ago
News Archive
Although targeted therapies have produced dramatic advances in our ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem.
PBS NewsHour on Monday aired the second installment in its "Food for 9 Billion" series, in which "Sam Eaton of Homelands Productions goes to the fishing village of Humay-Humay" in the Philippines and "speaks with families about their concerns that future generations won't enjoy the same access to fish as a food staple and way of life," the PBS NewsHour blog "The Rundown" reports.
Over the course of the 20th Century, doctors waged war against infectious bacterial illness with the best new weapon they had: antibiotics.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, said today that the recent announcement by the Centers for Medicare & Medicade Services (CMS) of a 15% increase in the payment rate of proton therapy for hospital based centers beginning in 2012 strengthens the economic case for the proton centers now under development by the Company.
› Verified 9 days ago
Evolve Therapy And Associates, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 11259 Anvil Ct, Naperville, IL 60564 Phone: 630-383-1109 | |
Claudia Hantel Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1975 Saddle Farm Ln, Naperville, IL 60564 Phone: 630-730-4504 | |
Adrienne Adams Md And Associates, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1979 N Mill St, Suite 202, Naperville, IL 60563 Phone: 630-420-7660 | |
Metropolitan Family Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 S Washington St, Naperville, IL 60540 Phone: 630-784-4801 | |
Soft Landing Interventins Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 Bond St, Naperville, IL 60563 Phone: 630-261-9220 Fax: 630-689-1786 | |
Care Clinics Of Naperville Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 121 N Washington St, Naperville, IL 60540 Phone: 630-357-2012 | |
Grow Wellness Group Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 200 E 5th Ave Ste 109, Naperville, IL 60563 Phone: 331-305-4009 |